| Primary |
| Hypercholesterolaemia |
26.0% |
| Hyperlipidaemia |
8.2% |
| Hypertension |
7.7% |
| Diabetes Mellitus |
6.6% |
| Spinal Cord Disorder |
6.1% |
| Anticoagulant Therapy |
5.1% |
| Antisocial Behaviour |
5.1% |
| Acute Myocardial Infarction |
4.1% |
| Cardiac Disorder |
4.1% |
| Type 2 Diabetes Mellitus |
4.1% |
| Depression |
3.6% |
| Blood Pressure |
2.6% |
| Dyslipidaemia |
2.6% |
| Urticaria |
2.6% |
| Blood Cholesterol Increased |
2.0% |
| Gout |
2.0% |
| Hypothyroidism |
2.0% |
| Pain |
2.0% |
| Vitamin Supplementation |
2.0% |
| Blood Cholesterol |
1.5% |
|
| Pancreatitis |
10.0% |
| Headache |
6.0% |
| Hyperkalaemia |
6.0% |
| Respiratory Disorder |
6.0% |
| Spontaneous Haematoma |
6.0% |
| Tongue Oedema |
6.0% |
| Transaminases Increased |
6.0% |
| Yellow Skin |
6.0% |
| Blood Glucose Decreased |
4.0% |
| Chest Pain |
4.0% |
| Convulsion |
4.0% |
| Gait Disturbance |
4.0% |
| Gynaecomastia |
4.0% |
| Haematuria |
4.0% |
| Hepatitis Toxic |
4.0% |
| Muscular Weakness |
4.0% |
| Myalgia |
4.0% |
| Myelitis Transverse |
4.0% |
| Optic Nerve Infarction |
4.0% |
| Palpitations |
4.0% |
|
| Secondary |
| Acute Myocardial Infarction |
17.7% |
| Hypercholesterolaemia |
14.6% |
| Myocardial Ischaemia |
14.6% |
| Diabetes Mellitus |
8.3% |
| Hyperlipidaemia |
8.3% |
| Hypertension |
6.3% |
| Prophylaxis |
5.2% |
| Drug Use For Unknown Indication |
4.2% |
| Ischaemic Cardiomyopathy |
3.1% |
| Blood Cholesterol |
2.1% |
| Cardiac Disorder |
2.1% |
| Hypersensitivity |
2.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Urticaria |
2.1% |
| Anticoagulant Therapy |
1.0% |
| Antiinflammatory Therapy |
1.0% |
| Device Therapy |
1.0% |
| Dizziness |
1.0% |
| Dyslipidaemia |
1.0% |
|
| Vomiting |
21.7% |
| Skin Discolouration |
13.0% |
| Muscular Weakness |
8.7% |
| Myelitis Transverse |
8.7% |
| Neutropenia |
8.7% |
| Palpitations |
8.7% |
| Visual Impairment |
8.7% |
| Hepatitis |
4.3% |
| Malaise |
4.3% |
| Myositis |
4.3% |
| Product Formulation Issue |
4.3% |
| Sleep Disorder |
4.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.9% |
| Hypertension |
15.6% |
| Pain |
7.4% |
| Rheumatoid Arthritis |
5.5% |
| Diabetes Mellitus |
5.2% |
| Product Used For Unknown Indication |
4.9% |
| Osteoporosis |
4.3% |
| Hypercholesterolaemia |
3.7% |
| Prophylaxis |
3.7% |
| Depression |
2.8% |
| Dyslipidaemia |
2.8% |
| Atrial Fibrillation |
2.5% |
| Hyperlipidaemia |
2.1% |
| Hiv Infection |
1.8% |
| Neuralgia |
1.8% |
| Sedative Therapy |
1.8% |
| Hyperparathyroidism Secondary |
1.5% |
| Insomnia |
1.5% |
| Mineral Supplementation |
1.5% |
| Myocardial Ischaemia |
1.5% |
|
| Myocardial Infarction |
11.3% |
| Staphylococcal Bacteraemia |
7.5% |
| Death |
5.7% |
| Erectile Dysfunction |
5.7% |
| Pancreatitis Acute |
5.7% |
| Pyrexia |
5.7% |
| Renal Failure Acute |
5.7% |
| Toxic Epidermal Necrolysis |
5.7% |
| Vomiting |
5.7% |
| Cystitis |
3.8% |
| Hepatitis Toxic |
3.8% |
| Intestinal Obstruction |
3.8% |
| Metastases To Lymph Nodes |
3.8% |
| Mutism |
3.8% |
| Myalgia |
3.8% |
| Renal Failure Chronic |
3.8% |
| Septic Arthritis Streptococcal |
3.8% |
| Tooth Disorder |
3.8% |
| Urticaria |
3.8% |
| Vasculitis |
3.8% |
|
| Interacting |
| Oedema |
17.6% |
| Anticoagulant Therapy |
11.8% |
| Chest Pain |
11.8% |
| Hypercholesterolaemia |
11.8% |
| Pain |
11.8% |
| Thrombosis Prophylaxis |
11.8% |
| Dyslipidaemia |
5.9% |
| Gout |
5.9% |
| Hypertension |
5.9% |
| Obesity |
5.9% |
|
| Oedema |
66.7% |
| Myositis |
33.3% |
|
